APLS DCF Valuation - Apellis Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 17.72 USD 2.84% Market Closed

Market Cap: $2.3B

	Apellis Pharmaceuticals Inc NASDAQ:APLS	US
S	Sony Financial Group Inc TSE:8729	JP
G	Genpharmasec Ltd BSE:531592	IN
Y	Yorkey Optical International (Cayman) Ltd HKEX:2788	HK
	Samwha Electronics Co Ltd KRX:011230	KR
	Nichias Corp TSE:5393	JP
	Star Diamond Corp TSX:DIAM	CA
	Ggtoor Inc OTC:GTOR	US
L	Live Oak Bancshares Inc NYSE:LOB	US
	Brain Scientific Inc OTC:BRSF	US
	KPIT Technologies Ltd NSE:KPITTECH	IN
	Aukett Swanke Group PLC LSE:AUK	UK
R	Reliq Health Technologies Inc SWB:MHN2	CA

APLS's DCF value cannot be reliably calculated.

Relative Valuation Wall Street Price Targets

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.